Ketamine (Spravato) is a treatment for major depression.
Major Depressive Disorder is a debilitating disorder characterized by low self-esteem, low energy, and low interest in doing anything enjoyable. The daily impact on one’s life is often catastrophic, leading to poor work performance, difficult interpersonal relationships, and can ultimately progress to pervasive suicidal thoughts.
Approximately 16 million of the US teen/adult population suffers from depression (including post-partum depression), and unfortunately ONE THIRD of those do not respond to any typical antidepressant therapy. Depression is a leading cause of disability.
Spavato is nasal a FDA approved nasal spray form of Ketamine. Ketamine causes neurogenesis, which is different than traditional anti-depressants that work on the chemical levels in a patient’s brain. As many as 75-80% of people with depression have a significant improvement in their mood in as little as 1-2 treatments.